On The Fly
|
Check out this morning's… ShowHide Related Items >><< - 04/28/22
- Sio Gene Therapies terminates licensing agreements with UMass
- 02/11/22
- Sio Gene Therapies sees cash runway into 2H23
- 01/31/22
- Sio Gene Therapies appoints CFO David Nassif as interim CEO
- 01/31/22
- Sio Gene to prioritize AXO-AAV-GM therapies, terminate AXO-Lenti-PD agreement
- 06/13/22
- Oracle jumps 9% to $69.74 after Q4 results beat estimates
- 06/13/22
- Oracle reports short-term deferred revenues $8.4B
- 06/13/22
- Oracle CEO: 'Major increase in demand' in infrastructure cloud business in Q4
- 06/13/22
- Oracle reports Q4 total cloud revenue $2.9B, up 19% in USD, up 22% in CC
- 06/13/22
- Outset Medical announces shipment hold on new Tablo Systems pending FDA review
- 02/16/22
- Outset Medical names president and CEO Leslie Trigg as board chair
- 06/09/22
- Li-Cycle rises 9.9%
- 06/09/22
- Li-Cycle rises 12.0%
- 06/01/22
- Li-Cycle to receive $200M investment from Glencore
- 05/17/22
- Li-Cycle's recycling facility in Arizona begins commercial operations
- 06/13/22
- Kaival Brands, Philip Morris enter agreement for distribution of ENDS products
- 04/18/22
- Kaival Brands expands distribution for Bidi Vapor
- 02/18/22
- Kaival Brands regains compliance with Nasdaq
- 02/03/22
- Kaival Brands: Court grants judicial stay of MDO by FDA to Bidi Vapor
DAWN Day One Biopharmaceuticals - 06/12/22
- Day One announces initial data from pivotal FIREFLY-1 trial of Tovorafenib
- 05/23/22
- Day One announces first patients dosed in Phase 1b/2 combination study
- 03/07/22
- Day One Biopharmaceuticals announces program highlights
- 03/07/22
- Day One Biopharmaceuticals expects cash to fund operations into 2024
- $52.02 /
-6.625 (-11.30%) - 06/14/22
- Coinbase drops 7% to $48.60 after cutting 18% of workforce, JPMorgan downgrade
- 06/14/22
- Coinbase not updating outlook provided on May 10
- 06/14/22
- Coinbase sees $40M-$45M in charges from cutting 1,100 jobs
- 06/14/22
- Coinbase reducing size of team by about 18%
- 05/31/22
- Coda Octopus CFO Mike Midgley to retire, Nathan Parker to succeed
- 03/16/22
- Coda Octopus expects CFO to retire in FY22
- 06/14/22
- Core & Main sees FY22 adjusted EBITDA $710M-$750M
- 06/07/22
- Core & Main signs agreement to acquire Earthsavers Erosion Control
- 03/31/22
- Core & Main to acquire Lock City Supply Inc
- 03/30/22
- Core & Main sees FY22 revenue up high single to low double-digit range
CLR Continental Resources - 06/14/22
- Continental Resources announces receipt of $70.00 per share take private offer
- 06/07/22
- Northern Oil and Gas to acquire interests in Williston Basin for $170M in cash
- 04/27/22
- Continental Resources increases quarterly dividend 22% to 28c per share
- 04/27/22
- Continental Resources updates 2022 production guidance
- 06/07/22
- Minim announces WiFi 6 Modem/Router placement in Best Buy locations
- 04/20/22
- Best Buy launches home pick-up recycling service
- 04/07/22
- Best Buy CEO: Our purpose is to enrich lives through technology
- 03/03/22
- Best Buy increases quarterly dividend 26%, announces $5B share repurchase plan
CLR Continental Resources - 06/14/22 Barclays
- Continental Resources price target raised to $77 from $67 at Barclays
- 04/25/22 Susquehanna
- Continental Resources price target raised to $66 from $61 at Susquehanna
- 04/21/22 Truist
- Continental Resources price target raised to $95 from $80 at Truist
- 04/19/22 Barclays
- Continental Resources price target raised to $67 from $64 at Barclays
- 04/08/22 Maxim
- Kaival Brands initiated with a Buy at Maxim
- 03/31/22 Truist
- Core & Main price target lowered to $28 from $32 at Truist
- 03/31/22 Barclays
- Core & Main upgraded to Overweight from Equal Weight at Barclays
- 02/17/22 BofA
- Core & Main downgraded to Underperform at BofA on 'modest' volume growth
- 02/17/22 BofA
- Core & Main downgraded to Underperform from Neutral at BofA
- 06/03/22 Morgan Stanley
- Li-Cycle price target lowered to $8 from $10 at Morgan Stanley
- 04/07/22 Citi
- Li-Cycle price target lowered to $10 from $11 at Citi
- 02/10/22 Morgan Stanley
- Li-Cycle downgraded to Equal Weight from Overweight at Morgan Stanley
- 01/11/22 Piper Sandler
- Li-Cycle price target lowered to $15 from $18 at Piper Sandler
- 04/28/22 H.C. Wainwright
- Sio Gene Therapies downgraded to Sell from Buy at H.C. Wainwright
- 04/28/22 Cantor Fitzgerald
- Sio Gene Therapies downgraded to Neutral from Overweight at Cantor Fitzgerald
- 02/02/22 BTIG
- Sio Gene Therapies price target lowered to $3 from $8 at BTIG
- 02/01/22 SVB Securities
- SVB Leerink downgrades Sio Gene Therapies to Market Perform, cuts target to $1
- 06/14/22 JPMorgan
- Oracle price target lowered to $82 from $100 at JPMorgan
- 06/14/22 BMO Capital
- Oracle price target lowered to $86 from $92 at BMO Capital
- 06/14/22 Deutsche Bank
- Oracle reported 'exceptional' Q4 results, says Deutsche Bank
- 06/14/22 Stifel
- Oracle price target lowered to $72 from $83 at Stifel
- 02/14/22 Alliance Global Partners
- Coda Octopus price target lowered to $9 from $14 at Alliance Global Partners
- 10/05/21 Alliance Global Partners
- Coda Octopus price target raised to $14 from $13 at Alliance Global Partners
- 06/14/21 Alliance Global Partners
- Coda Octopus price target raised to $13 from $11 at Alliance Global
- $52.02 /
-6.625 (-11.30%) - 06/14/22 JPMorgan
- JPMorgan downgrades Coinbase on 'extreme decline' in crypto markets
- 06/14/22 JPMorgan
- Coinbase downgraded to Neutral from Overweight at JPMorgan
- 06/06/22 TD Cowen
- Coinbase well capitalized to navigate 'crypto winter,' says Cowen
- 05/26/22 TD Cowen
- Cowen says Coinbase 'built to last,' starts at Outperform
DAWN Day One Biopharmaceuticals - 06/13/22 Wedbush
- Day One Biopharmaceuticals price target raised to $35 from $32 at Wedbush
- 06/13/22 Piper Sandler
- Piper reiterates $35 target on Day One after 'new high mark' data
- 06/13/22 JPMorgan
- JPMorgan sees Day One shares moving to mid-teens, low-$20s on data
- 05/13/22 Wedbush
- Day One Biopharmaceuticals removed from Best Ideas List at Wedbush
- 06/14/22 TD Cowen
- Outset Medical price target lowered to $33 from $60 at Cowen
- 06/14/22 Stifel
- Outset Medical price target lowered to $30 from $55 at Stifel
- 03/02/22 BofA
- Outset Medical reinstated with a Buy at BofA
- 02/17/22 Morgan Stanley
- Outset Medical upgraded at Morgan Stanley on inflecting Home opportunity
- 06/14/22 BofA
- Tractor Supply upgraded to Buy at BofA as consumers shift spending
- 06/14/22 BofA
- BofA cuts Best Buy to Neutral as consumers pull back on discretionary spending
- 06/14/22 BofA
- Best Buy downgraded to Neutral from Buy at BofA
- 05/25/22 DA Davidson
- Best Buy price target raised to $110 from $107 at DA Davidson
- 06/14/22
- Sio Gene Therapies reports Q4 EPS (18c), consensus (20c)
- 02/11/22
- Sio Gene Therapies reports Q3 EPS (35c), consensus (22c)
- 06/13/22
- Oracle sees Q1 EPS $1.04-$1.08, consensus $1.13
- 06/13/22
- Oracle reports Q4 adjusted EPS $1.54, consensus $1.37
- 06/13/22
- Notable companies reporting after market close
- 03/10/22
- Oracle sees Q4 EPS $1.40-$1.44, consensus $1.38
- 06/13/22
- Outset Medical sees Q2 revenue 'at least' $25M, suspends FY22 guidance
- 05/04/22
- Outset Medical narrows FY22 revenue view to $144M-$150M from $142M-$150M
- 05/04/22
- Outset Medical reports Q1 EPS (67c), consensus (72c)
- 02/16/22
- Outset Medical sees FY22 revenue $142M-$160M, consensus $140.44M
- 06/14/22
- Li-Cycle reports Q2 EPS (12c), consensus (10c)
- 03/17/22
- Li-Cycle reports Q1 EPS 17c, consensus (7c)
- 01/27/22
- Li-Cycle reports Q4 EPS ($1.31), consensus (3c)
DAWN Day One Biopharmaceuticals - 05/12/22
- Day One Biopharmaceuticals reports Q1 EPS (48c), consensus (38c)
- 03/07/22
- Day One Biopharmaceuticals reports 2021 EPS ($4.62), consensus ($3.36)
- $52.02 /
-6.625 (-11.30%) - 05/10/22
- Coinbase reports Q1 EPS ($1.98) vs. $3.80 last year
- 05/10/22
- Coinbase reports Q1 revenue $1.165B, consensus $1.48B
- 05/10/22
- Notable companies reporting after market close
- 02/24/22
- Coinbase reports Q4 adjusted EBITDA $1.21B vs. $288M y/y
- 06/14/22
- Coda Octopus reports Q2 EPS 6c vs. 20c a year ago
- 03/16/22
- Coda Octopus Group reports Q2 EPS 11c vs. 10c a year ago
- 06/14/22
- Core & Main reports Q1 EPS 50c, consensus 35c
- 03/30/22
- Core & Main reports Q4 EPS 28c, consensus 22c
CLR Continental Resources - 05/04/22
- Continental Resources reports Q1 adjusted EPS $2.65, consensus $2.34
- 02/14/22
- Continental Resources reports Q4 adjusted EPS $1.79, consensus $1.69
- 05/24/22
- Best Buy cuts FY23 EPS view $8.40-$9.00 from $8.85-$9.15, consensus $8.90
- 05/24/22
- Best Buy reports Q1 EPS $1.57, consensus $1.61
- 05/23/22
- Notable companies reporting before tomorrow's open
|
Earnings
|
Reports Q2 revenue $4.98M… Reports Q2 revenue $4.98M vs. $5.37M a year ago. Annmarie Gayle, Coda's Chairman and CEO, commented: "Our financial results for the SQ2022 were not in-line with our internal Management Business Plan for the period or published Management Revenue Targets and were down over the comparable period last year. One of our key performance measures for our business is the level of proposals submitted to prospective customers for orders in the period. In the reporting period, our level of proposals submitted to customers has increased over the comparable SQ2021. We are therefore disappointed that the conversion of these opportunities into firm sales has been slower than anticipated in the SQ2022 period. We believe that some of the factors which are slowing down the placement of orders by our customers, particularly for our Services Business, relate to uncertainties arising from the supply chain where there is significant scarcity of components and raw materials in conjunction with sharp price increases. This results in multiple iterations of the same proposals, resulting in delay in the placement of these orders. In addition, we believe that the Pandemic has caused delays in receiving orders from Europe which has resulted in a sharp fall in revenues generated from Europe in the SQ2022 period compared to the SQ2021. Further details can be found in our Form 10-Q for the SQ2022 period." ShowHide Related Items >><< - 05/31/22
- Coda Octopus CFO Mike Midgley to retire, Nathan Parker to succeed
- 03/16/22
- Coda Octopus expects CFO to retire in FY22
- 02/14/22 Alliance Global Partners
- Coda Octopus price target lowered to $9 from $14 at Alliance Global Partners
- 10/05/21 Alliance Global Partners
- Coda Octopus price target raised to $14 from $13 at Alliance Global Partners
- 06/14/21 Alliance Global Partners
- Coda Octopus price target raised to $13 from $11 at Alliance Global
- 03/16/22
- Coda Octopus Group reports Q2 EPS 11c vs. 10c a year ago
|
Hot Stocks
|
Coda Octopus Group… Coda Octopus Group announced the retirement of its current CFO, Mike Midgley who will formally leave his post in June 2022 and the appointment of Nathan Parker who will succeed Midgley as CFO, effective June 13. Parker will be based in Salt Lake City. Nathan Parker joins the Group as a well-qualified and experienced financial professional who will bring a number of additional skills to this role. From 2021 to 2022, Nathan was CFO for the Water Treatment business of Franklin Electric, a Fort Wayne Indiana based $2B global leading manufacturer and distributor of water and fuel systems for use across residential, commercial, agricultural, industrial, and municipal applications. ShowHide Related Items >><< - 03/16/22
- Coda Octopus expects CFO to retire in FY22
- 02/14/22 Alliance Global Partners
- Coda Octopus price target lowered to $9 from $14 at Alliance Global Partners
- 10/05/21 Alliance Global Partners
- Coda Octopus price target raised to $14 from $13 at Alliance Global Partners
- 06/14/21 Alliance Global Partners
- Coda Octopus price target raised to $13 from $11 at Alliance Global
- 03/16/22
- Coda Octopus Group reports Q2 EPS 11c vs. 10c a year ago
|